/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
+0.08%
Natural Gas
-3.61%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-0.13%
VIX
N/A
Economic Calendar
EUR/USD
+0.08%
Natural Gas
-3.61%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-0.13%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Crude Inventories Rise By 2.1 Million Barrels, Exceeding Analyst Estimates
16 minutes ago
October PPI Rises 0.2%, Supporting Fed Rate Cut Hopes as Inflation and Jobs Steady
about 3 hours ago
Disney’s Streaming Fuels Optimism; PPI Data May Forecast Fed’s Next Steps
about 4 hours ago
Eurozone Economy Expands by 0.4% in Q3 2024 but US Tariff Threat Remains
about 6 hours ago
UK Wage Growth and Jobless Rate Rise, Fueling BoE Rate Path Uncertainty
2 days ago
Michigan Consumer Sentiment Rises To 73.0, Beating Analyst Expectations
6 days ago
US Dollar Forecast: DXY Hits New 2024 High as Trump Policies Pressure Euro and Boost Bitcoin
17 minutes ago
Meme Coin Analysis: Market Correction Impacts Bonk, Dogwifhat, Popcat Rally Towards All-Time Highs
25 minutes ago
Dow Jones Gains as Disney Earnings Impress; Nasdaq & S&P 500 Face Inflation Fears
14 minutes ago
Natural Gas Price Outlook – Natural Gas Continues to Look Strong
about 2 hours ago
Gold Price Outlook – Gold Continues to See Pressures
about 2 hours ago
Crude Oil Price Outlook – Crude Continues to See Support at The Same Area
about 2 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
NVAX
profile
Novavax, Inc.
Follow
NVAX
(
Nasdaq - US
)
Open
7.75
-0.01 (-0.19%)
in
:
usd
•
As of: Nov 14, 2024 11:33
UTC -5
Open
7.79
High
7.93
Low
7.55
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
About
Novavax, Inc.
CEO
John C. Jacobs
Headquarters
700 quince orchard road
gaithersburg, md 20878, united states
Auditor
Ernst & Young LLP
Employees
1,543
Share Holders
177
Website
www.novavax.com
Industry
biotechnology
Sector
health technology
Company Overview
Novavax, Inc. is a biotechnology company engaged in developing innovative vaccines to prevent serious infectious diseases. The company is also developing proprietary immune stimulating saponin-based adjuvants, namely Matrix-M, which already enhanced immune responses and were well-tolerated in multiple studies.?Novavax developed its own coronavirus vaccine NVX-CoV2373. The company is currently marketing two versions of NVX-CoV2373, one marketed in partnership with the Serum Institute of India under the trade name Covovax and another version produced by Novavax and marketed under the trade name Nuvaxovid.?Novavax developed NanoFlu, its recombinant quadrivalent seasonal influenza vaccine candidate with Matrix M adjuvant for senior patients aged 65 years and above.?ResVax a respiratory syncytial virus vaccine is being developed to protect infants by immunizing mothers against the disease. Novavax is discussing the opportunity to bring ResVax to the market globally with the help of commercial partners.
Novavax, Inc.
Statistics
Valuation Measures
Market Capitalization
2
1.24B
Enterprise Value
889.83M
Enterprise Value/EBITDA
(ttm)
-3.49
Price to Earnings Ratio
(ttm)
N/A
Price to Book
(mrq)
N/A
Price to Sales
(ttm)
1.53
Price to Cash
(ytd)
N/A
Profitability
Gross Margin
(ttm)
54.92%
Operating Margin
(ttm)
-32.18%
Profit Margin
(ttm)
-62.32%
Return on Equity
(ttm)
N/A
Return on Invested Capital
(ttm)
9.57%
Return on Assets
(ttm)
-17.20%
Income Statement
Revenue
(ttm)
885.19M
Revenue Per Share
(ttm)
5.53
Gross Profit
(ttm)
564.15M
EBITDA
(ttm)
3
-254.65M
Net Income Avi to Common
(ttm)
-284.86M
Diluted EPS
(ttm)
-2.26
Share Statistics
Beta (5Y Monthly)
2.10
52-Week Change
24.20%
S&P500 52-Week Change
32.96%
S&P500 Member
No
Stock Optionable
Yes
Total Shares Outstanding
1
160.19M
Dividend Yield
0.00%
Float
4
158.49M
%
Held by Insiders
1.00%
%
Held by Institutions
53.04%
Balance Sheet
Total Cash
(mrq)
920.08M
Total Cash Per Share
(mrq)
5.74
Total Debt
(mrq)
233.31M
Total Debt/Equity
(mrq)
-54.03%
Current Ratio
(mrq)
1.04%
Quick Ratio
(mrq)
1.03%
Book Value Per Share
(mrq)
-2.70
Cash Flow
Operating Cash Flow Per Share
(ytd)
1.39
Free Cash Flow
(ytd)
220.96M
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker